Glibenclamide Tablets IP 5 mg Exporter

Glibenclamide Tablets IP 5 mg Exporter in India – Healthy Inc

Glibenclamide Tablets IP 5 mg Exporter product packaging

Glibenclamide Tablets IP 5 mg | Exporter

Product image for Glibenclamide Tablets IP 5 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic NameGlibenclamide
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP
Product TypeTablet
CategoryAntidiabetic drugs
SubcategoryAntidiabetic drugs
Active IngredientGlibenclamide
Strength5 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntidiabetic drugs

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for Glibenclamide Tablets IP 5 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. Monotherapy as an adjunct to diet and exercise for glycemic control in type 2 diabetes mellitus. 2. Combination therapy with other oral antidiabetic agents or insulin when dual therapy is required.
Full Description

Healthy Inc invites international procurement enquiries for Glibenclamide Tablets IP 5 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic nameGlibenclamide
CompositionGlibenclamide
Strength5 mg
CategoryAntidiabetic drugs
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For Glibenclamide Tablets IP 5 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally with meals or immediately before food intake as directed by the physician. Recommended dosage should be individualized based on glycemic response and HbA1c targets. Maintain regular blood glucose self-monitoring during initiation and titration.
Side EffectsCommon: Mild gastrointestinal discomfort, nausea, flatulence, abdominal fullness, diarrhea. Uncommon: Hypoglycemia (when combined with other antidiabetic agents), transient metallic taste, mild headache. Rare: Skin rash, urticaria, elevated hepatic transaminases.
Warnings and PrecautionsHypoglycemia Risk: Concomitant use with sulfonylureas or insulin secretagogues heightens hypoglycemic risk; ensure immediate access to fast-acting carbohydrates. Renal & Hepatic Monitoring: Periodically assess serum creatinine, eGFR, and liver function tests during long-term therapy.
Contraindications1. Known hypersensitivity to Glibenclamide or formulation excipients.
2. Diabetic ketoacidosis, hyperosmolar hyperglycemic state, or diabetic coma.
3. Severe renal impairment (eGFR < 30 mL/min) or advanced hepatic insufficiency.
4. Acute metabolic acidosis.
Drug Interactions1. Sulfonylureas, Meglitinides & Insulin: Enhanced hypoglycemic effect requiring dose adjustments.
2. Corticosteroids, Thiazides & Sympathomimetics: May attenuate glycemic control, requiring upward titration.
3. Alcohol: May potentiate hypoglycemia or risk of metabolic acidosis.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for Glibenclamide Tablets IP 5 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for Glibenclamide Tablets IP 5 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for Glibenclamide Tablets IP 5 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for Glibenclamide Tablets IP 5 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for Glibenclamide Tablets IP 5 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Tags

Glibenclamide Tablets IP 5 mg ExporterGlibenclamide 5 mgRegulatory Dossiers & International ShippingHealthy Inc

Product Hashtags

#Glibenclamide#Exporter#PharmaB2B

Related Products

Related Posts